Hebang biotechnology updates on bond conversions, financial guarantees

Sichuan Hebang Biotechnology reported that as of September 30, 2025, its "Hebang Convertible Bond" saw cumulative conversions totaling 282,000 yuan, resulting in 141,000 new shares. This represents 0.0016% of the company's total shares before conversion. For the third quarter of 2025 alone, 53,000 yuan of convertible bonds were converted into 26,500 shares. The remaining unconverted bonds amounted to 4,599,718,000 yuan, or 99.9939% of the total issuance.

Concurrently, the company provided an update on its financial guarantees, specifically a 200 million yuan guarantee for its controlled subsidiary, Wujun Chongqing Guangneng Co. Ltd. The actual outstanding guarantee provided to Wujun Chongqing Guangneng totals 1,152.6892 million yuan. This guarantee falls within previously approved limits and is covered by the company's internal decision-making process.

As of September 30, 2025, the aggregate external guarantees by the company and its subsidiaries reached 7,663.0665 million yuan, representing 41.14% of its most recently audited net assets. The company clarified that there are no overdue external guarantees, and no guarantees have been provided for controlling shareholders or related parties.